China Approves Brain Implant That Helps Paralyzed Patients Grasp

After four years of being unable to hold a cup, a man identified as Dong can now lift one, take a drink, and set it back down on his own.

He's one of 36 people benefiting from a breakthrough brain-computer interface that just received China's highest medical device approval for commercial use. The NEO system, developed by Shanghai-based Neuracle Medical Technology, earned clearance on March 13 to help patients with quadriplegia regain hand function.

The technology reads minds to move hands. When patients think about grasping something, coin-sized sensors implanted near the brain detect those signals and wirelessly transmit them to a robotic glove that moves their fingers.

The system targets people ages 18 to 60 who lost hand function from cervical spinal cord injuries but still have some upper arm movement. All participants in clinical trials showed improvements in hand grasping ability, and researchers observed signs of neural remodeling in some cases, suggesting the brain may actually rewire itself with help from the device.

Engineer Zeng Yuhang explained that the implant sits above the brain's protective membrane rather than piercing it, reducing potential damage while maintaining strong signal quality. The device needs no batteries, powered instead by a wireless magnetic coil that eliminates the need for removal and charging.

Patients can typically operate the system independently at home about one month after surgery. Dong, who joined the trial in October 2024, progressed so much through rehabilitation that he eventually wrote simple phrases like "thank you" and his own name without any device assistance at all.

The Ripple Effect

Two days after the approval, Shanghai announced three new brain-computer interface research centers bringing together over 300 researchers, clinicians, and industry experts. The momentum signals China's serious investment in expanding this technology beyond hands to potentially helping paralyzed patients walk again.

Dr. Mao Ying, president of Huashan Hospital where most clinical trials occurred, cautioned that the technology remains in early stages and requires extensive training and rehabilitation. But the approval marks a turning point where brain-computer interfaces move from laboratory experiments to real medical tools people can use in their daily lives.

For patients like Dong who spent years unable to perform basic tasks, that transition from research to reality means independence measured in simple moments: holding a cup, writing their name, grasping what was lost.